Samsung Medical Center

🇰🇷South Korea

Country: 🇰🇷South Korea

Ownership: Subsidiary

Established: 1994-01-01

Employees: 501

Market Cap: -

Website: http://www.samsunghospital.com

Clinical Trials

Phase II, Single-arm Study of AZD1775 Monotherapy in Relapsed Small Cell Lung Cancer Patients With MYC Family Amplification or CDKN2A Mutation Combined With TP53 Mutation

Phase 2

Terminated

Conditions: Small Cell Lung Cancer

Interventions: Drug: AZD1775

First Posted Date: 2016-02-23

Last Posted Date: 2018-09-20

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 7

Registration Number: NCT02688907

Locations: 🇰🇷
Keunchil Park, Seoul, Korea, Republic of

Study to Evaluate the Safety and Efficacy of Sirolimus, in Subject With Refractory Solid Tumors

Phase 4

Completed

Conditions: Refractory Solid Tumors

Interventions: Drug: sirolimus

First Posted Date: 2016-02-23

Last Posted Date: 2022-06-15

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 6

Registration Number: NCT02688881

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

The Molecular Screening Study for the Umbrella Trial (SUKSES) in Relapsed Small Cell Lung Cancer Patients [SUKSES-S]

Recruiting

Conditions: Neuroendocrine Carcinoma
Small Cell Lung Cancers

Interventions: Other: No treatment is included in this protocol.

First Posted Date: 2016-02-23

Last Posted Date: 2024-01-03

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 797

Registration Number: NCT02688894

Locations: 🇰🇷
Ulsan University Hospital, Ulsan, Korea, Republic of
🇰🇷
Chungbuk University Hospital, Chungbuk, Korea, Republic of
🇰🇷
Gachon University Gil Medical Center, Incheon, Korea, Republic of

and more 3 locations

The Lamina Cribrosa (LC) Changes in the Eyes After Laser-Assisted in Situ Keratomileusis (LASIK)

Completed

Conditions: The Lamina Cribrosa and Optic Nerve Head Changes

Interventions: Device: Exposed to the high pressure during the surgery

First Posted Date: 2016-02-08

Last Posted Date: 2016-02-08

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 40

Registration Number: NCT02676557

Follow-Up Study of Safety of Pneumostem® in Premature Infants With Intraventricular Hemorrhage

Conditions: Intracranial Hemorrhages
Mesenchymal Stem Cells
Newborn Infant

First Posted Date: 2016-02-04

Last Posted Date: 2019-04-09

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 9

Registration Number: NCT02673788

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Study of Ibrutinib in Combination With Rituximab-CHOP in Epstein-Barr Virus-positive Diffuse Large B-cell Lymphoma

Phase 2

Completed

Conditions: Epstein-Barr Virus-positive Diffuse Large B-cell Lymphoma

Interventions: Drug: Ibrutinib
Drug: Rituximab
Drug: Cyclophosphamide
Drug: Doxorubicin
Drug: vincristine
Drug: Prednisolone

First Posted Date: 2016-02-02

Last Posted Date: 2020-10-22

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 24

Registration Number: NCT02670616

Locations: 🇰🇷
Samsung Medical Center, Seoul, Seoul, Gangnam-gu, Korea, Republic of

A Trial of Evonail® Solution for Prevention or Treatment of Onycholysis

Not Applicable

Completed

Conditions: Docetaxel Chemotherapy
Breast Cancer

Interventions: Drug: EVONAIL® solution

First Posted Date: 2016-02-02

Last Posted Date: 2017-04-28

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 100

Registration Number: NCT02670603

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

MR-based Collateral Imaging to Predict Response to Endovascular Treatment of Stroke (FAST-COLL Study)

Conditions: Stroke

First Posted Date: 2016-01-29

Last Posted Date: 2017-04-26

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 120

Registration Number: NCT02668627

Locations: 🇰🇷
Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of

The Effect of Steroid Pulse Therapy for the Reduction of Acute Rejection Episode in Subclinical Borderline Changes

Not Applicable

Conditions: Chronic Renal Failure

Interventions: Drug: Methylprednisolone

First Posted Date: 2016-01-27

Last Posted Date: 2016-04-06

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 154

Registration Number: NCT02664493

Locations: 🇰🇷
Samsung medical center, Seoul, Korea, Republic of

Augmented Pulse Pressure Variation to Predict Fluid Responsiveness in Open Laparotomy

Completed

Conditions: Gynecologic Neoplasms
Abdominal Neoplasms

Interventions: Other: Augmented ventilation
Other: Fluid loading

First Posted Date: 2016-01-12

Last Posted Date: 2016-03-04

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 38

Registration Number: NCT02653469

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy